1CALL FOR PAPERS前插12Dopamine: an immune transmitterSarah Thomas Broome, Krystal Louangaphay, Kevin A. Keay, Gian Marco Leggio, Giuseppe Musumeci, Alessandro Castorina2173-21853The role of sequestosome 1/p62 protein in amyotrophic lateral sclerosis and frontotemporal dementia pathogenesisAdriana Delice Foster, Sarah Lyn Rea2186-21944Mounting evidence of FKBP12 implication in neurodegenerationGabriella Caminati, Piero Procacci2195-22025Using antifibrinolytics to tackle neuroinflammationStanimir Atsev, Nikola Tomov2203-22066Medicinal plants and natural products as neuroprotective agents in age-related macular degenerationFrancisco Bosch-Morell, Victoria Villagrasa, Teresa Ortega, Nuria Acero, Dolores Mu?oz-Mingarro, M. Eugenia González-Rosende, Encarna Castillo, M. Amparo Sanahuja, Pilar Soriano, Isabel Martínez-Solís2207-22167Nafamostat mesylate attenuates the pathophysiologic sequelae of neurovascular ischemiaGeorge Zaki Ghali, Michael George Zaki Ghali2217-22348Engineering mesenchymal stromal/stem cell-derived extracellular vesicles with improved targeting and therapeutic efficiency for the treatment of central nervous system disordersAlexandra M. Iavorovschi, Aijun Wang2235-22369Adaptable retinal ganglion cell function: assessing autoregulation of inner retina pathwaysTsung-Han Chou, Vittorio Porciatti2237-223810Prion-like domain disease-causing mutations and misregulation of alternative splicing relevance in limb-girdle muscular dystrophy(LGMD) 1GCristina Batlle, Salvador Ventura2239-224011Neurotrophin-3-mediated locomotor recovery: a novel therapeutic strategy targeting lumbar neural circuitry after spinal cord injuryQi Han, Xiao-Ming Xu2241-224212How and why does photobiomodulation change brain activity?John Mitrofanis, Luke A. Henderson2243-224413Activation of tyrosine phosphatases in the progression of Alzheimer's diseaseAlexandre F. R. Stewart, Hsiao-Huei Chen2245-224614Targeting cannabidiol to specific areas of the brain: an ultrasound-based strategyJacopo Junio Valerio Branca, Donatello Carrino, Alessandra Pacini2247-224815Remote ischemic conditioning: the brain's endogenous defense against strokeCaleb J. Heiberger, Tej Mehta, Jae Kim, Divyajot S. Sandhu2249-225016Targeting the transferrin receptor to develop erythropoietin for Alzheimer's diseaseRachita K. Sumbria2251-225217Recent advances on the role of long non-coding RNAs in Alzheimer's diseaseKyle Doxtater, Manish K. Tripathi, Mohammad Moshahid Khan2253-225418Whole-brain three-dimensional imaging for quantification of drug targets and treatment effects in mouse models of neurodegenerative diseasesHenrik H. Hansen, Urmas Roostalu, Jacob Hecksher-S?rensen2255-225719Activation of β2 adrenergic receptors promotes adult hippocampal neurogenesisValeria Bortolotto, Mariagrazia Grilli2258-225920Small molecules to prevent the neurodegeneration caused by α-synuclein aggregationSamuel Pe?a-Díaz, Jordi Pujols, Salvador Ventura2260-2261 